Stockscreener 앱 받기
88.18
2.31%
2.05
시간 외 거래:
88.18
전일 마감가:
$86.13
열려 있는:
$84.71
하루 거래량:
327.51K
Relative Volume:
0.63
시가총액:
$4.89B
수익:
$76.81M
순이익/손실:
$-162.42M
주가수익비율:
-29.49
EPS:
-2.99
순현금흐름:
$-122.49M
1주 성능:
+0.72%
1개월 성능:
+3.59%
6개월 성능:
+34.43%
1년 성능:
+1.94%
1일 변동 폭
$84.00
$89.71
1주일 범위
$84.00
$92.34
52주 변동 폭
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
명칭
Arcellx Inc
전화
240-327-0603
주소
800 BRIDGE PARKWAY, REDWOOD CITY
ACLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
88.18 | 4.78B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | Stifel | Buy |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-10-08 | 개시 | Redburn Atlantic | Buy |
| 2024-09-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-03-07 | 개시 | Morgan Stanley | Overweight |
| 2024-01-04 | 재확인 | Needham | Buy |
| 2023-12-19 | 개시 | Scotiabank | Sector Outperform |
| 2023-10-30 | 개시 | TD Cowen | Outperform |
| 2023-10-17 | 개시 | UBS | Buy |
| 2023-05-18 | 개시 | Truist | Buy |
| 2023-04-14 | 개시 | Robert W. Baird | Outperform |
| 2023-03-14 | 개시 | Stifel | Buy |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-13 | 재개 | BofA Securities | Buy |
| 2022-10-31 | 개시 | Guggenheim | Buy |
| 2022-10-27 | 개시 | Needham | Buy |
| 2022-07-20 | 개시 | Canaccord Genuity | Buy |
| 2022-03-01 | 개시 | BofA Securities | Buy |
| 2022-03-01 | 개시 | SVB Leerink | Outperform |
모두보기
Arcellx Inc 주식(ACLX)의 최신 뉴스
Canaccord Genuity Group Forecasts Strong Price Appreciation for Arcellx (NASDAQ:ACLX) Stock - MarketBeat
(ACLX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
What institutional flow reveals about Arcellx Inc.M&A Rumor & Fast Entry Momentum Alerts - newser.com
How Arcellx Inc. stock performs during Fed tightening cycles2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Risk vs reward if holding onto Arcellx Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com
Is Arcellx Inc. stock a dividend growth opportunityWeekly Trade Review & Real-Time Volume Analysis - newser.com
Can technical indicators confirm Arcellx Inc.’s reversal2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Why Arcellx Inc. is moving todayMarket Activity Report & Entry Point Confirmation Signals - newser.com
Arcellx (ACLX): Canaccord Genuity Raises Price Target to $130 | - GuruFocus
Trend analysis for Arcellx Inc. this weekMarket Risk Summary & Daily Profit Focused Screening - newser.com
Canaccord Genuity raises Arcellx stock price target on higher anito-cel launch revenue - Investing.com UK
Canaccord Genuity raises Arcellx stock price target on higher anito-cel launch revenue By Investing.com - Investing.com South Africa
Arcellx (NASDAQ: ACLX) to present iMMagine-1 update at ASH; pre-BLA completed - Stock Titan
Tools to assess Arcellx Inc.’s risk profileWeekly Trade Report & Capital Efficient Trading Techniques - newser.com
Arcellx, Inc. $ACLX Shares Sold by Pier Capital LLC - MarketBeat
Using Python tools to backtest Arcellx Inc. strategiesJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Signal strength of Arcellx Inc. stock in tech scannersWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Fresh Analyst Optimism on CAR T-Cell Advances Might Change the Case for Investing in Arcellx (ACLX) - simplywall.st
Will Arcellx Inc. stock split again soon2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Arcellx (ACLX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Is Arcellx Inc. stock a buy for dividend growthJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Arcellx Insiders Sell US$3.9m Of Stock, Possibly Signalling Caution - 富途牛牛
Canaccord Genuity Sticks to Their Buy Rating for Arcellx Inc (ACLX) - The Globe and Mail
Arcellx’s iMMagine-3 Study: A Potential Game-Changer for Multiple Myeloma Treatment - TipRanks
What drives Arcellx Inc stock priceEnergy Sector Updates & Minimal Capital Growth Ideas - earlytimes.in
Will Arcellx Inc. stock benefit from green energy trendsPortfolio Value Summary & Risk Controlled Stock Alerts - fcp.pa.gov.br
Arcellx Advances in Autoimmune Treatment with Anitocabtagene Autoleucel Study - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Arcellx Inc (ACLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):